Another meta-analysis evaluated the prognostic value of the PD-L1 expression in tumor infiltrating immune cells and suggested that PD-L1 positivity in tumor infiltrating immune cells indicated a better prognosis in breast cancer patients12. This evidence concerns the gene CD274 and breast carcinoma.